The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

GSK plc GSK announced that the FDA has approved Exdensur (depemokimab-ulaa), an ultra-long-acting IL-5–targeting biologic, as ...

Indiana University School of Medicine researchers are taking a closer look at how young patients respond to biologic ...

AstraZeneca ($AZN) announced an update on their ongoing clinical study. In a recent clinical study update, AstraZeneca has completed a Phase 2a ...

If the FeNO level is not raised, it is recommended that the patient be offered either a Long-Acting Muscarinic Antagonist ...

A peak flow meter is a simple, small, hand-held tool that can help you maintain control of asthma by providing a measurement of how well air moves out of the lungs. After blowing into the device, the ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

This new data was the result of a recent case-controlled study that aimed to assess the effects of a PDL that provides an exemption from out-of-pocket cost sharing for patients’ asthma medications on ...

Objective Systemic corticosteroids for 5–7 days are standard care for asthma exacerbations, but the optimal duration and ...

Dr. Stephen Wasserman answers the question: 'What Is A Rescue Medicine?' — -- Question: What is a rescue medicine and when is it used for asthma? Answer: A rescue medicine is a medicine used in ...